Lidocaine hydrochloride monohydrate - CAS 6108-05-0
Catalog number:
6108-05-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C14H25ClN2O2
Molecular Weight:
288.81
COA:
Inquire
Targets:
Sodium Channel
Description:
Lidocaine hydrochloride monohydrate is the hydrochloride monohydrate form of lidocaine, which is an aminoethylamide and a prototypical member of the amide class anesthetics. It is a local anesthetic and cardiac depressant used as an antiarrhythmia agent. It has properties as a class IB antiarrhythmic, a long-acting membrane stabilizing agent used against ventricular arrhythmia. It interacts with voltage-gated Na+ channels in the nerve cell membrane and blocks the transient increase in permeability of excitable membranes to Na+. It works by blocking sodium channels and thus decreasing the rate of contractions of the heart. It can cause low blood pressure and an irregular heart rate.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
White solid
Synonyms:
2’,6’-Acetoxylidide,2-(diethylamino)-,hydrochloride,hydrate;Acetamide,2-(diethylamino)-n-(2,6-dimethylphenyl)-,monohydrochloride;2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride hydrate;Lidocaine Hydrochloride;Xyloneural
Solubility:
H2O: soluble
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
Lidocaine hydrochloride monohydrate is a local anesthetic and cardiac depressant used as an antiarrhythmia agent. It can cause low blood pressure and an irregular heart rate.
Quality Standard:
CP standard
Quantity:
Kilograms to Tons
Boiling Point:
350.8ºC at 760 mmHg
Melting Point:
68.5ºC
InChIKey:
YECIFGHRMFEPJK-UHFFFAOYSA-N
InChI:
InChI=1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2
Canonical SMILES:
CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.O.Cl
1.Comparative Evaluation of Mental Incisal Nerve Block, Inferior Alveolar Nerve Block, and Their Combination on the Anesthetic Success Rate in Symptomatic Mandibular Premolars: A Randomized Double-blind Clinical Trial.
Aggarwal V1, Singla M2, Miglani S3, Kohli S3. J Endod. 2016 Apr 14. pii: S0099-2399(16)30024-3. doi: 10.1016/j.joen.2016.02.015. [Epub ahead of print]
INTRODUCTION: The purpose of this study was to compare the effectiveness of mental incisive nerve block (MINB) and inferior alveolar nerve block (IANB) that were given alone or in combination to provide anesthesia to symptomatic mandibular premolars.
2.Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration.
Qiu XS1, Chauveau S1, Anyukhovsky EP1, Rahim T1, Jiang YP1, Harleton E1, Feinmark SJ1, Lin RZ1, Coronel R1, Janse MJ1, Opthof T1, Rosen TS1, Cohen IS2, Rosen MR1. Circ Arrhythm Electrophysiol. 2016 Apr;9(4). pii: e003655. doi: 10.1161/CIRCEP.115.003655.
BACKGROUND: Drugs are screened for delayed rectifier potassium current (IKr) blockade to predict long QT syndrome prolongation and arrhythmogenesis. However, single-cell studies have shown that chronic (hours) exposure to some IKr blockers (eg, dofetilide) prolongs repolarization additionally by increasing late sodium current (INa-L) via inhibition of phosphoinositide 3-kinase. We hypothesized that chronic dofetilide administration to intact dogs prolongs repolarization by blocking IKr and increasing INa-L.
3.Simultaneous Treatment with Subcutaneous Injection of Golimumab and Intra-articular Injection of Triamcinolone Acetonide (K-Method) in Patients with Rheumatoid Arthritis Undergoing Switching of Biologics: Retrospective Case-Control Study.
Kanbe K1, Chiba J1, Inoue Y1, Taguchi M1, Yabuki A1, Deguchi T1. Clin Med Insights Arthritis Musculoskelet Disord. 2016 Apr 4;9:45-9. doi: 10.4137/CMAMD.S38442. eCollection 2016.
BACKGROUND: Tight control of severe rheumatoid arthritis (RA) in patients with high disease activity, even when using biologics, is sometimes difficult using a treat-to-target strategy. Switching from one biologic to another is associated with lower efficacy than that in treatment-naive cases. We developed the K-method that involves simultaneous treatment with golimumab and intra-articular joint injection of triamcinolone acetonide (TA) in patients undergoing switching of biologics. We performed this retrospective case-control study to investigate the efficacy of achieving an immediate treatment response using the K-method.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sodium Channel Products


CAS 5370-01-4 Mexiletine Hydrochloride

Mexiletine Hydrochloride
(CAS: 5370-01-4)

Mexiletine HCl belongs to Class IB anti-arrhythmic group of medicines, inhibits sodium channels to reduce the inward sodium current.

CAS 550-83-4 Propoxycaine hydrochloride

Propoxycaine hydrochloride
(CAS: 550-83-4)

Propoxycaine hydrochloride is the hydrochloride salt form of Propoxycaine used to control the pain of intramuscular injection of penicillin as well as in dentis...

CAS 28721-07-5 Oxcarbazepine

Oxcarbazepine
(CAS: 28721-07-5)

Oxcarbazepine inhibits the binding of [3H]BTX to sodium channels with IC50 of 160 μM and also inhibits the influx of 22Na+ into rat brain synaptosomes with IC50...

CAS 22059-60-5 Disopyramide phosphate

Disopyramide phosphate
(CAS: 22059-60-5)

Disopyramide phosphate is an oral antiarrhythmic agent for the treatment of cardiac arrhythmias. Disopyramide is a sodium channel blocker and therefore classifi...

CAS 84057-84-1 Lamotrigine

Lamotrigine
(CAS: 84057-84-1)

Lamotrigine is an anticonvulsant, inhibiting glutamate release, possibly through inhibition of Na+, K+ and Ca2+ currents.

Sodium Channel inhibitor 1
(CAS: 1198117-23-5)

Sodium Channel inhibitor 1, a 3-Oxoisoindoline-1-carboxamide derivative, is an effective voltage-gated sodium channel blocker that could be used for pain treatm...

PF-05089771
(CAS: 1235403-62-9)

PF-05089771, a Nav1.7 channel blocker, has been studied to have potential effect in the treatment of chronic neuropathic pain. It is still under Phase II clinic...

CAS 31883-05-3 Moricizine

Moricizine
(CAS: 31883-05-3)

Moricizine, a Phenothiazine derivative, is effective in suppressing premature ventricular contractions, couplets, and nonsustained ventricular tachycardia. And ...

CAS 6108-05-0 Lidocaine hydrochloride monohydrate

Lidocaine hydrochloride monohydrate
(CAS: 6108-05-0)

Lidocaine hydrochloride monohydrate is the hydrochloride monohydrate form of lidocaine, which is an aminoethylamide and a prototypical member of the amide class...

CAS 396-01-0 Triamterene

Triamterene
(CAS: 396-01-0)

Triamterene blocks epithelial Na+ channel (ENaC) in a voltage-dependent manner with IC50 of 4.5 μM.

CAS 536-43-6 Dyclonine Hydrochloride

Dyclonine Hydrochloride
(CAS: 536-43-6)

Dyclonine HCl is a hydrochloride salt form of dyclonine which is an oral anaesthetic.

CAS 2016-88-8 Amiloride HCl

Amiloride HCl
(CAS: 2016-88-8)

Amiloride HCl is a relatively selective inhibitor of the epithelial sodium channel (ENaC), used in the management of hypertension and congestive heart failure.

CAS 1443373-17-8 AM-2099

AM-2099
(CAS: 1443373-17-8)

AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1.7 (IC50= 0.16 μM) with excellent selectivity against hNav1.5 (IC50 > 30 uM).

CAS 61-12-1 Dibucaine Hydrochloride

Dibucaine Hydrochloride
(CAS: 61-12-1)

Dibucaine HCl is a local anesthetics.Among the most potent and toxic of the long-acting local anesthetics, current use of it is generally restricted to spinal a...

CAS 74517-78-5 Indecainide

Indecainide
(CAS: 74517-78-5)

Indecainide is a Sodium channel antagonists originated by Eli Lilly. Treatment for Arrhythmias and Ventricular arrhythmias was discontinued.

Evenamide
(CAS: 1092977-61-1)

Evenamide is a selective voltage-gated sodium and​/or calcium channel modulator, including subtypes Nav1.3, Nav1.7, and Nav1.8. It may be potentia useful in pre...

Nav1.7-IN-2
(CAS: 1332295-35-8)

Nav1.7-IN-2, a voltage-gated sodium channels, could be probably effective in chronic pain therapy. IC50: 80 nM.

CAS 944261-79-4 A-803467

A-803467
(CAS: 944261-79-4)

A-803467 is a sodium channel blocker that potently blocks tetrodotoxin-resistant currents (IC50=140 nM).

CAS 50-12-4 Mephenytoin

Mephenytoin
(CAS: 50-12-4)

Mephenytoin is known to target sodium channel protein type 5 subunit alpha. It is a hydantoin-derivative anticonvulsant used to control various partial seizures...

CAS 1234365-97-9 Tenapanor HCl

Tenapanor HCl
(CAS: 1234365-97-9)

Tenapanor, also known as AZD-1722 and RDX 5791, is a first-in-class, small-molecule inhibitor of the gastrointestinal sodium/hydrogen exchanger NHE3. Tenapanor ...

Chemical Structure

CAS 6108-05-0 Lidocaine hydrochloride monohydrate

Quick Inquiry

Verification code

Featured Items